Novo Nordisk - ADR

NYSE:NVO   12:38:00 PM EDT
89.04
-1.71 (-1.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)154.50B
Current PE3.60
Forward PE 28.63
2yr Forward PE 25.88
See more stats
Estimates Current Quarter
Revenue$5.21 Billion
Adjusted EPS$0.80
See more estimates
10-Day MA$88.27
50-Day MA$83.60
200-Day MA$73.56
See more pivots

Novo Nordisk - ADR Stock, NYSE:NVO

Novo All?©, Novo All?©, Bagsv??rd, Capital Region 2880
Phone: +45.44.44.88.88
Number of Employees: 45323

Description

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsv??rd, Denmark.